Samir Mitragotri

I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA.

CAGE Bio, Inc. transforms ionic liquids into healthcare solutions. Its ionic liquid platform uses structural heterogeneity of cations and anions to enhance membrane permeation. The company was founded by Nitin Joshi and Samir Mitragotri and is headquartered in San Carlos, CA.

I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA.

I2o Therapeutics, Inc. develops injection pills for biological therapies. It offers revolutionary oral delivery platform such as high bioavailability, low cost of goods, superior drug loading, injection free delivery, readily scalable, and compatible with diverse drug types. The company was founded by Samir Mitragotri, Ravi Srinivasan, Kelly Ibsen, and Tyler Brown in 2019 and is headquartered in Allston, MA.

CAGE Bio, Inc. transforms ionic liquids into healthcare solutions. Its ionic liquid platform uses structural heterogeneity of cations and anions to enhance membrane permeation. The company was founded by Nitin Joshi and Samir Mitragotri and is headquartered in San Carlos, CA.